[go: up one dir, main page]

CR7069A - Derivados de pirazol para el tratamiento de vih - Google Patents

Derivados de pirazol para el tratamiento de vih

Info

Publication number
CR7069A
CR7069A CR7069A CR7069A CR7069A CR 7069 A CR7069 A CR 7069A CR 7069 A CR7069 A CR 7069A CR 7069 A CR7069 A CR 7069A CR 7069 A CR7069 A CR 7069A
Authority
CR
Costa Rica
Prior art keywords
derivatives
hiv treatment
pirazol derivatives
pirazol
preparation
Prior art date
Application number
CR7069A
Other languages
English (en)
Inventor
Howard Jones Lyn
Eric Mowbray Charles
Anthony Price David
Duncan Selby Matthew
Anthony Stupple Paul
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0108999A external-priority patent/GB0108999D0/en
Priority claimed from GB0127426A external-priority patent/GB0127426D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of CR7069A publication Critical patent/CR7069A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Esta invencion se refiere a derivados de pirazol de formula o a sales, solvatos o derivados farmaceuticamente aceptables de los mismos, en la que R1 A R4 se definen en la descripcion, y a procedimientos para la preparacion de los mismos, a intermedios usados en su preparacion, a composiciones que los contienen y a los usos de tales derivados.
CR7069A 2001-04-10 2003-09-09 Derivados de pirazol para el tratamiento de vih CR7069A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0108999A GB0108999D0 (en) 2001-04-10 2001-04-10 Pyrazole derivatives
GB0127426A GB0127426D0 (en) 2001-11-15 2001-11-15 Pyrazole derivatives

Publications (1)

Publication Number Publication Date
CR7069A true CR7069A (es) 2007-12-17

Family

ID=26245955

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7069A CR7069A (es) 2001-04-10 2003-09-09 Derivados de pirazol para el tratamiento de vih

Country Status (43)

Country Link
US (4) US7109228B2 (es)
EP (2) EP1762567B1 (es)
JP (1) JP3806090B2 (es)
KR (1) KR100569324B1 (es)
CN (1) CN100408564C (es)
AR (2) AR037319A1 (es)
AT (2) ATE556059T1 (es)
AU (1) AU2002242926B2 (es)
BG (1) BG66349B1 (es)
BR (1) BRPI0208811B8 (es)
CA (1) CA2443449C (es)
CR (1) CR7069A (es)
CY (2) CY1107626T1 (es)
CZ (1) CZ305099B6 (es)
DE (1) DE60219292T2 (es)
DK (2) DK1762567T3 (es)
DO (1) DOP2002000378A (es)
EA (1) EA007184B1 (es)
EE (1) EE05400B1 (es)
ES (2) ES2385659T3 (es)
GE (1) GEP20053619B (es)
HK (1) HK1063781A1 (es)
HR (1) HRP20030783B1 (es)
HU (1) HU229025B1 (es)
IL (2) IL157875A0 (es)
IS (1) IS2734B (es)
MA (1) MA27009A1 (es)
ME (1) ME00558A (es)
MX (1) MXPA03009380A (es)
MY (1) MY146669A (es)
NO (1) NO326518B1 (es)
NZ (1) NZ529403A (es)
OA (1) OA12501A (es)
PA (1) PA8543601A1 (es)
PE (1) PE20021056A1 (es)
PL (3) PL216985B1 (es)
PT (2) PT1762567E (es)
RS (1) RS51166B (es)
SI (2) SI1377556T1 (es)
SK (1) SK287858B6 (es)
TW (1) TWI333488B (es)
UY (1) UY27248A1 (es)
WO (1) WO2002085860A1 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12501A (en) * 2001-04-10 2006-05-26 Pfizer Pyrazole derivatives for treating HIV.
WO2003057673A1 (en) * 2001-12-28 2003-07-17 Bayer Pharmaceuticals Corporation 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
JP4228587B2 (ja) 2002-05-22 2009-02-25 昭和電工株式会社 アミノメチル基含有ベンズアミド化合物の製造方法
US20040132793A1 (en) * 2002-09-16 2004-07-08 Pfizer Inc. Pyrazole derivatives
GB0221477D0 (en) * 2002-09-16 2002-10-23 Pfizer Ltd Chemical compounds
US6933312B2 (en) 2002-10-07 2005-08-23 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
GB0223234D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
GB0223232D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
EP1608629A1 (en) 2003-03-24 2005-12-28 F. Hoffmann-La Roche Ag Benzyl-pyridazinons as reverse transcriptase inhibitors
JP2006526017A (ja) * 2003-05-14 2006-11-16 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
US7102001B2 (en) * 2003-12-12 2006-09-05 Bristol-Myers Squibb Company Process for preparing pyrrolotriazine
CA2554696C (en) 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
WO2005100305A1 (en) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
EP1740533A1 (en) 2004-04-22 2007-01-10 Warner-Lambert Company LLC Androgen modulators
AR048650A1 (es) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
JP4874965B2 (ja) 2004-07-08 2012-02-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲン調節剤
EP1874732A1 (en) 2005-04-20 2008-01-09 Pfizer Limited Pyrazole derivatives as progesterone receptor antagonists
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
CA2628844C (en) * 2005-11-08 2011-12-06 Pfizer Limited Pyrazole derivatives and their medical use
KR20080108539A (ko) 2006-04-12 2008-12-15 머크 앤드 캄파니 인코포레이티드 피리딜 아미드 ｔ-형 칼슘 채널 길항제
DE602007013573D1 (de) 2006-08-16 2011-05-12 Hoffmann La Roche Nicht-nukleosidische reverse-transkriptase-hemmer
US20080096950A1 (en) * 2006-10-19 2008-04-24 Karl Richard Gibson Compounds Useful In Therapy
US9280685B2 (en) * 2006-12-08 2016-03-08 Johnnie R. Jackson System and method for portable medical records
WO2008135824A1 (en) * 2007-05-02 2008-11-13 Pfizer Limited Oxyalkylpyrazole compounds useful in therapy
EP2170836A1 (en) 2007-06-22 2010-04-07 F. Hoffmann-Roche AG Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
US8637513B2 (en) 2007-10-24 2014-01-28 Merck Sharp & Dohme Corp. Heterocycle phenyl amide T-type calcium channel antagonists
JP2011500808A (ja) * 2007-10-24 2011-01-06 メルク・シャープ・エンド・ドーム・コーポレイション 複素環アミドｔ型カルシウムチャネルアンタゴニスト
KR101610607B1 (ko) 2007-12-21 2016-04-07 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스 화합물
DK3127542T3 (en) 2010-01-27 2018-11-12 Viiv Healthcare Co ANTIVIRAL THERAPY
JP6085553B2 (ja) * 2010-04-13 2017-02-22 センターハート・インコーポレイテッドＳｅｎｔｒｅＨＥＡＲＴ， Ｉｎｃ． 心臓にデバイスをアクセスおよび送達するためのデバイスおよび方法
CN103517990A (zh) 2010-10-07 2014-01-15 通用医疗公司 癌症生物标志物
KR101861883B1 (ko) * 2010-12-06 2018-05-28 글락소 그룹 리미티드 Lp-PLA₂에 의해 매개되는 질환 또는 상태의 치료에 사용하기 위한 피리미디논 화합물
WO2013050873A1 (en) 2011-10-07 2013-04-11 Phivco Uk Limited Process for the preparation of lersivirine
WO2013050884A1 (en) 2011-10-07 2013-04-11 Phivco Uk Limited Process for the preparation of lersivirine
WO2013057593A1 (en) 2011-10-07 2013-04-25 Phivco Uk Limited Process for the preparation of lersivirine
EP2716632A1 (en) 2012-10-05 2014-04-09 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses
WO2014074628A1 (en) * 2012-11-08 2014-05-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds for treating hiv and methods for using the compounds
US10026064B2 (en) 2013-09-13 2018-07-17 Microsoft Technology Licensing, Llc Automatically recommending updates based on stored lifecycle information
JPWO2015060348A1 (ja) * 2013-10-23 2017-03-09 大日本住友製薬株式会社 縮合ピラゾール誘導体
EP3140289A1 (en) * 2014-05-06 2017-03-15 E. I. du Pont de Nemours and Company Fungicidal pyrazoles
EP3760208B1 (en) 2014-06-25 2024-05-29 The General Hospital Corporation Targeting human satellite ii (hsatii)
ES2968785T3 (es) * 2014-10-31 2024-05-14 Hoffmann La Roche Nuevos compuestos de piridiniloxi- y feniloxipirazolilo
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef
JOP20180092A1 (ar) * 2017-10-13 2019-04-13 Gilead Sciences Inc مثبطات hiv بروتياز
EP4317972A3 (en) 2018-02-06 2024-03-13 The General Hospital Corporation Repeat rna as biomarkers of tumor immune response
KR102114389B1 (ko) * 2018-05-02 2020-05-25 이화여자대학교 산학협력단 신규 소듐채널 저해 화합물, 이의 제조방법, 및 이를 포함하는 소듐채널 관련 질환의 예방 또는 치료용 약학적 조성물
WO2020056564A1 (zh) 2018-09-17 2020-03-26 南通纺织丝绸产业技术研究院 基于金属氢化物/钯化合物体系制备1,3-二羰基化合物的方法
WO2020078402A1 (zh) * 2018-10-18 2020-04-23 南京圣和药业股份有限公司 作为TGF-βR1抑制剂的化合物及其应用
CN113527304A (zh) * 2020-04-17 2021-10-22 南京圣和药物研发有限公司 喹啉类TGF-β1抑制剂的制备方法
CN113527306A (zh) * 2020-04-17 2021-10-22 南京圣和药物研发有限公司 喹啉类TGF-β1抑制剂的晶型
WO2023243678A1 (ja) 2022-06-15 2023-12-21 日産化学株式会社 ピラゾール化合物、その製造中間体、及び有害生物防除剤

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303200A (en) * 1963-11-05 1967-02-07 American Home Prod Pyrazole-1-ethanol derivatives
US3963742A (en) * 1974-07-12 1976-06-15 American Cyanamid Company 1,2-Dialkyl-3,4,5-trisubstituted pyrazolium salts as herbicidal agents
US4009277A (en) * 1975-01-17 1977-02-22 American Cyanamid Company 1,2-Dialkyl-3,4,5-trisubstituted pyrazolium salts as fungicidal agents
US4041046A (en) 1975-06-06 1977-08-09 American Cyanamid Company 1,2-Dialkyl-3,4,5-trisubstituted pyrazole compounds
US4000301A (en) 1975-11-14 1976-12-28 American Cyanamid Company Fungicidal use of 4-alkoxypyrazoles
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
JPH0565237A (ja) 1991-09-10 1993-03-19 Mitsubishi Heavy Ind Ltd メタノールを媒体としたエネルギ供給方法
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
FR2707295A1 (fr) 1993-06-07 1995-01-13 Rhone Poulenc Agrochimie Fongicides pyrazoles substitués en position 3 par un hétérocycle.
DE69408950T2 (de) 1993-12-14 1998-10-15 Mitsubishi Chem Corp N-Pyrazolylcarbamatderivate und Fungizide für Landwirtschaft und Gartenbau, die diese als aktive Bestandteile erhalten, Produktion und Zwischenprodukte
FR2722369B1 (fr) 1994-07-13 1998-07-10 Rhone Poulenc Agrochimie Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
PT786455E (pt) * 1994-09-26 2004-02-27 Shionogi & Co Derivados de imidazol
TW343232B (en) * 1994-10-13 1998-10-21 Chisso Corp Difluorooxymethane derivative and liquid crystal composition
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
JP4960565B2 (ja) * 2000-05-12 2012-06-27 ジェンザイム コーポレーション ＴＮＦαシグナル伝達のモジュレータ
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
OA12501A (en) * 2001-04-10 2006-05-26 Pfizer Pyrazole derivatives for treating HIV.

Also Published As

Publication number Publication date
GEP20053619B (en) 2005-09-26
EP1762567A1 (en) 2007-03-14
CY1107626T1 (el) 2013-04-18
HUP0303735A3 (en) 2004-07-28
CZ20032676A3 (cs) 2004-11-10
OA12501A (en) 2006-05-26
KR20040007496A (ko) 2004-01-24
PL217629B1 (pl) 2014-08-29
DE60219292D1 (de) 2007-05-16
BRPI0208811B1 (pt) 2018-03-13
US20090215712A1 (en) 2009-08-27
PE20021056A1 (es) 2002-12-03
NO20034523D0 (no) 2003-10-09
EE05400B1 (et) 2011-04-15
SK287858B6 (sk) 2012-01-04
MY146669A (en) 2012-09-14
US7109228B2 (en) 2006-09-19
DK1762567T3 (da) 2012-06-25
SI1762567T1 (sl) 2012-08-31
IL157875A0 (en) 2004-03-28
YU77503A (sh) 2006-05-25
HU229025B1 (en) 2013-07-29
SI1377556T1 (sl) 2007-08-31
US20120029192A1 (en) 2012-02-02
BG108244A (bg) 2005-04-30
AR037319A1 (es) 2004-11-03
PL217224B1 (pl) 2014-06-30
BR0208811A (pt) 2004-03-09
NZ529403A (en) 2005-06-24
PL216985B1 (pl) 2014-06-30
HRP20030783A2 (en) 2005-08-31
EA200300943A1 (ru) 2004-08-26
ES2385659T3 (es) 2012-07-27
IS2734B (is) 2011-04-15
HRP20030783B1 (en) 2011-11-30
AR076259A2 (es) 2011-06-01
KR100569324B1 (ko) 2006-04-07
IS6939A (is) 2003-09-04
US20030100554A1 (en) 2003-05-29
UY27248A1 (es) 2002-11-29
CN1514828A (zh) 2004-07-21
CA2443449A1 (en) 2002-10-31
PT1762567E (pt) 2012-07-16
NO20034523L (no) 2003-12-09
DOP2002000378A (es) 2002-10-15
CY1113515T1 (el) 2016-06-22
CZ305099B6 (cs) 2015-05-06
ATE358669T1 (de) 2007-04-15
HK1063781A1 (en) 2005-01-14
EE200300497A (et) 2004-02-16
EP1377556A1 (en) 2004-01-07
DK1377556T3 (da) 2007-07-16
MA27009A1 (fr) 2004-12-20
AU2002242926B2 (en) 2007-10-11
US20060020012A1 (en) 2006-01-26
NO326518B1 (no) 2008-12-22
PL396946A1 (pl) 2012-01-02
CA2443449C (en) 2008-11-04
BG66349B1 (bg) 2013-08-30
ATE556059T1 (de) 2012-05-15
US8063044B2 (en) 2011-11-22
SK12442003A3 (sk) 2004-12-01
PL365026A1 (en) 2004-12-27
PT1377556E (pt) 2007-06-06
JP2004531535A (ja) 2004-10-14
EA007184B1 (ru) 2006-08-25
WO2002085860A1 (en) 2002-10-31
ME00558A (en) 2011-12-20
MXPA03009380A (es) 2004-04-21
JP3806090B2 (ja) 2006-08-09
RS51166B (sr) 2010-10-31
EP1762567B1 (en) 2012-05-02
CN100408564C (zh) 2008-08-06
BRPI0208811B8 (pt) 2021-05-25
DE60219292T2 (de) 2008-04-10
PL398536A1 (pl) 2012-06-04
PA8543601A1 (es) 2002-10-31
IL157875A (en) 2010-05-17
EP1377556B1 (en) 2007-04-04
HUP0303735A2 (hu) 2004-03-01
US7435728B2 (en) 2008-10-14
TWI333488B (en) 2010-11-21
ES2283532T3 (es) 2007-11-01

Similar Documents

Publication Publication Date Title
CR7069A (es) Derivados de pirazol para el tratamiento de vih
PA8518801A1 (es) Derivados de 2-aminocarbonil-9h-purina
UY28671A1 (es) Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2
UY27516A1 (es) Bencimidazoles
CR8859A (es) Derivados de piridina
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
UY27350A1 (es) Azaindoles
CR9954A (es) Derivados de pirazina
GT200100132A (es) Derivados de pirazol
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
HN2003000417A (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
AR055070A1 (es) Una composicion farmaceutica de liberacion sostenida, proceso para la preparacion de dicha composicion, metodo para la utilizacion de la misma y su uso
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
DOP2006000193A (es) Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso
PA8511801A1 (es) Derivados de purina
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
CR9507A (es) Sulfonamidas de diarisulfona y sus usos
DOP2002000422A (es) Agentes antibacterianos.
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
CO5611124A2 (es) Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos
ECSP044999A (es) Agentes antidiabeticos
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
PA8589801A1 (es) Aminoalcoxiindoles